Ulixertinib hydrochloride

• Description:

  Ulixertinib hydrochloride (Ulixertinib HCl) is an orally available, selective and potent ERK1/2 inhibitor with anticancer and antitumor activity that inhibits the NB cell cycle and promotes apoptosis, and may be used in the study of solid tumors.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  469.79

• Molecular Formula:

  C21H23Cl3N4O2

• Notes:

  Research use only, not for human use.

• Receptor:

  ERK

• CAS Number:

  1956366-10-1